Stock Movers

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- PepsiCo (PEP) shares are higher as it reported core earnings per share for the second quarter that beat the average analyst estimate.
- AstraZeneca (AZN) shares are plunging after the company's gene silencer drug failed to help prevent heart problems in patients with a rare and potentially fatal disease. The announcement caused Astra shares to slump by as much as 9.9% in London trading, with the bigger issue being "a degree of credibility loss." A successful trial could have led to billions of dollars more in sales, but the trial results make Astra's ambition of more than $5 billion in Wainua sales "unlikely" due to the challenging route to approval.
- Levi Strauss (LEVI) shares are lower as its full-year forecast boost underwhelmed, despite its earnings beating the average analyst estimate.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- AstraZeneca and Ionis Pharmaceuticals Inc.’s gene silencer drug Wainua failed to help prevent heart problems in patients with a rare and potentially fatal disease of the organ. AstraZeneca’s shares slumped.

- Schott Pharma shares jump by a record 22% after the company improved its guidance for the full year, prompting an upgrade at RBC Capital Markets. The stock is trading at its highest level since October.
- Bulgaria’s government may not be able to secure funding for joint project with Rheinmetall for NATO-standard shell, gunpowder plant, Mediapool news website reports, citing Economy Minister Alexander Pulev.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Deutz agreed to buy military vehicle maker Flensburger Fahrzeugbau Gesellschaft mbH for €1.6 billion ($1.8 billion), expanding further into the defense sector to benefit from Europe’s rearmament drive.
- AstraZeneca and Ionis Pharmaceuticals Inc.’s gene silencer drug Wainua failed to help prevent heart problems in patients with a rare and potentially fatal disease of the organ. AstraZeneca’s shares slumped.
- Computacenter expects first-half adjusted profit before tax to be double the prior year’s first-half figure of £81.5m, following 2Q performance ahead of expectations.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Shares in Chinese artificial-intelligence model maker Zhipu surged as much as 22% in Hong Kong after the company priced a $4 billion share sale at the low end of the marketed range.
- Korean stocks rose earlier as SK Hynix’s US offering being oversubscribed boosted sentiment.
- Japanese stocks advanced as a rally in US chipmakers boosted tech shares, eclipsing anxiety over escalating Middle East tensions. Tokyo Electron shares rose as much as 6.2%.
See omnystudio.com/listener for privacy information.

Today’s biggest winners and losers in the stock market.
On this episode of Stock Movers:
Shares of Chevron (CVX), Occidental Petroleum (OXY), and US other energy stocks gained after President Trump said a tentative ceasefire with Iran is “over.” Speaking to reporters from the NATO summit in Ankara, Trump said the US would probably launch further strikes on Iran and could resume a blockade on the country’s ports, ratcheting up pressure on Tehran and raising the prospect of a return to all-out war. The US earlier on Tuesday revoked a waiver that allowed Tehran to sell its oil globally, in response to attacks on ships in the Strait of Hormuz that it blamed on the Islamic Republic. The moves posed the greatest threat yet to a ceasefire deal between the US and Iran and talks toward a broader agreement to end the war.
Shares of Broadcom (AVGO) closed nearly 5% higher after Apple indicated that it plans to follow through on a pledge to boost spending on US-made components. The iPhone maker says its expanded agreement with Broadcom is expected to top $30 billion. The deal will involve manufacturing more than 15 billion chips in the US, supporting hundreds of jobs, Apple said in a statement Wednesday. Apple will also help Broadcom upgrade its production facilities in Colorado. The announcement sheds new light on an arrangement that Broadcom announced Monday, when the chipmaker said the pact would run through 2031 but didn’t offer financial details.
Shares of Nvidia (NVDA) are back in the green after The Information reported China plans to allow the country’s largest AI companies to purchase a “small number” of H200 chips. The move raises the prospect of Nvidia regaining access to a market that has effectively been closed following US export restrictions, providing potential upside to China revenue expectations. The chipmaker’s stock had tumbled 16% since hitting an all-time high on May 14, losing roughly $1 trillion in market value in less than two months.
See omnystudio.com/listener for privacy information.